Search - tctmd.com

Displaying 1 - 20 of 51

Sort: Relevancy | Date

Presentation TCT 2025

The Inflammatory Core of Coronary Artery Disease

Presenter: Dominick J. Angiolillo

October 26, 2025

Presentation TCT 2024

Debate Con: Never

Presenter: Dominick Angiolillo

October 30, 2024

Presentation TCT 2024

Optimal Anti-Thrombotic Therapy in Acute MI

Presenter: Dominick Angiolillo

October 29, 2024

Presentation TCT 2023

Update on Current Treatment Targets for Secondary Prevention

Presenter: Dominick Angiolillo

October 26, 2023

News Conference News TCT 2023

LIFE-BTK: Bioresorbable Scaffold Holds Promise for Infrapopliteal CLTI

L.A. McKeown

October 25, 2023

Presentation TCT 2023

Standardizing the Language Around DAPT Post PCI: A Report From ARC With a Case Example

Presenter: Dominick Angiolillo

October 24, 2023

Presentation TCT 2021

PCI Phase: Bleeding Avoidance Strategies in the High Bleeding Risk Patient

Presenter: Dominick Angiolillo

November 06, 2021

Presentation TCT 2021

Debate: Follow the Bleeding Risk, Shorten DAPT!

Presenter: Dominick Angiolillo

November 05, 2021

News Conference News TCT 2020

Bivalirudin vs Heparin Patient-Level Meta-analysis Stirs an Old Debate

Shelley Wood

October 14, 2020

News Conference News TCT 2020

No Reperfusion Benefit From Crushed Prasugrel Prior to PCI: COMPARE CRUSH

L.A. McKeown

October 14, 2020

Presentation TCT 2019

Aspirin Variability, Interactions and Impact of Different Formulations

Presenter: Dominick Angiolillo

September 28, 2019

Presentation TCT 2019

Intravenous Platelet Inhibition for PCI and Bridging: Duration, Oral Drug Conversion, and More

Presenter: Dominick Angiolillo

September 27, 2019

Presentation TCT 2019

Noncardiac Surgery in ACS and After PCI: Role of Bridging and Timing to Restart Antiplatelet Therapy

Presenter: Dominick Angiolillo

September 27, 2019

Presentation TCT 2019

AFib Patients at High Ischemic Risk Post-PCI: Role of Triple Therapy or Potent P2Y12 Inhibition?

Presenter: Dominick Angiolillo

September 27, 2019

Presentation TCT 2019

Switch Therapies/ USE NOACs Instead of Coumadin

Presenter: Dominick Angiolillo

September 27, 2019

Presentation TCT 2019

Take Home for Clinicians: DM and STEMI

Presenter: Dominick Angiolillo

September 26, 2019

News Conference News TCT 2018

More GLOBAL LEADERS: No Benefit of Ticagrelor Monotherapy in New Analyses

Michael O'Riordan

September 24, 2018

Presentation TCT 2018

EVOLVE SHORT-DAPT: Three-Month Outcomes on Dual Antiplatelet Therapy in a High Bleeding Risk Population Treated With a Bioresorbable Polymer-Based Drug-Eluting Stent

Presenter: Dominick J. Angiolillo, Neal S. Kleiman, Ajay J. Kirtane

September 24, 2018

Presentation TCT 2018

SECURE-PCI: Impact of Timing of Atorvastatin Loading Dose in Patients Undergoing PCI for Acute Coronary Syndromes

Presenter: Dominick J. Angiolillo, Neal S. Kleiman, Renato D. Lopes

September 24, 2018

Presentation TCT 2018

HEALING-AMI: A Randomized Trial of Ticagrelor to Improve Left Ventricular Remodeling in ST-Segment Elevation Myocardial Infarction

Presenter: Dominick J. Angiolillo, Neal S. Kleiman, Yongwhi Park

September 24, 2018

Advertisement

The Inflammatory Core of Coronary Artery Disease

Debate Con: Never

Optimal Anti-Thrombotic Therapy in Acute MI

Update on Current Treatment Targets for Secondary Prevention

LIFE-BTK: Bioresorbable Scaffold Holds Promise for Infrapopliteal CLTI

Standardizing the Language Around DAPT Post PCI: A Report From ARC With a Case Example

PCI Phase: Bleeding Avoidance Strategies in the High Bleeding Risk Patient

Debate: Follow the Bleeding Risk, Shorten DAPT!

Bivalirudin vs Heparin Patient-Level Meta-analysis Stirs an Old Debate

No Reperfusion Benefit From Crushed Prasugrel Prior to PCI: COMPARE CRUSH

Aspirin Variability, Interactions and Impact of Different Formulations

Intravenous Platelet Inhibition for PCI and Bridging: Duration, Oral Drug Conversion, and More

Noncardiac Surgery in ACS and After PCI: Role of Bridging and Timing to Restart Antiplatelet Therapy

AFib Patients at High Ischemic Risk Post-PCI: Role of Triple Therapy or Potent P2Y12 Inhibition?

Switch Therapies/ USE NOACs Instead of Coumadin

Take Home for Clinicians: DM and STEMI

More GLOBAL LEADERS: No Benefit of Ticagrelor Monotherapy in New Analyses

EVOLVE SHORT-DAPT: Three-Month Outcomes on Dual Antiplatelet Therapy in a High Bleeding Risk Population Treated With a Bioresorbable Polymer-Based Drug-Eluting Stent

SECURE-PCI: Impact of Timing of Atorvastatin Loading Dose in Patients Undergoing PCI for Acute Coronary Syndromes

HEALING-AMI: A Randomized Trial of Ticagrelor to Improve Left Ventricular Remodeling in ST-Segment Elevation Myocardial Infarction

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content